- Home
- ALT vs GRVY Comparison
ALT vs GRVY Comparison
Compare ALT & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALT | GRVY |
|---|---|---|
| Founded | 1997 | 2000 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.5M | 455.3M |
| IPO Year | 2005 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ALT | GRVY |
|---|---|---|
| Price | $2.82 | $67.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $17.67 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 72.4K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.05 |
| Revenue Growth | ★ 105.00 | N/A |
| 52 Week Low | $2.56 | $54.54 |
| 52 Week High | $6.44 | $74.75 |
Technical Indicators
Market Signals| Indicator | ALT | GRVY |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 60.48 |
| Support Level | $2.72 | $60.79 |
| Resistance Level | $3.20 | $74.75 |
| Average True Range (ATR) | 0.12 | 2.90 |
| MACD | 0.03 | 1.09 |
| Stochastic Oscillator | 49.45 | 65.08 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. The gaming products of the company include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation. Geographically, it derives maximum revenue from Taiwan.